ESR1/SYNE1 Polymorphism and Invasive Epithelial Ovarian Cancer Risk: An Ovarian Cancer Association Consortium Study

Jennifer A. Doherty, Mary Anne Rossing, Kara L. Cushing-Haugen, Chu Chen, David J. Van Den Berg, Anna H. Wu, Malcolm C. Pike, Roberta B. Ness, Kirsten Moysich, Georgia Chenevix-Trench, Jonathan Beesley, Penelope M. Webb, Jenny Chang-Claude, Shan Wang-Gohrke, Marc T. Goodman, Galina Lurie, Pamela J. Thompson, Michael E. Carney, Estrid Hogdall, Susanne Kruger KjaerClaus Hogdall, Ellen L. Goode, Julie M. Cunningham, Brooke L. Fridley, Robert A. Vierkant, Andrew Berchuck, Patricia G. Moorman, Joellen M. Schildkraut, Rachel T. Palmieri, Daniel W. Cramer, Kathryn L. Terry, Hannah P. Yang, Montserrat Garcia-Closas, Stephen Chanock, Jolanta Lissowska, Honglin Song, Paul D.P. Pharoah, Mitul Shah, Barbara Perkins, Valerie McGuire, Alice S. Whittemore, Richard A. Di Cioccio, Aleksandra Gentry-Maharaj, Usha Menon, Simon A. Gayther, Susan J. Ramus, Argyrios Ziogas, Wendy Brewster, Hoda Anton-Culver, Celeste Leigh Pearce

Research output: Contribution to journal › Article › peer-review

60 Scopus citations

Fingerprint

Dive into the research topics of 'ESR1/SYNE1 Polymorphism and Invasive Epithelial Ovarian Cancer Risk: An Ovarian Cancer Association Consortium Study'. Together they form a unique fingerprint.

Medicine & Life Sciences